Smoking Clinical Trial
Official title:
Neuroimaging Attentional Impairment During Abstinence
The broad objective of this proposal is to identify functional neuroanatomical correlates of
impairments in sustained attention during smoking abstinence. We will measure changes in
performance and regional blood oxygenation levels using fMRI while smokers and non-smokers
complete a task designed to assess sustained attention—or the continuous monitoring of
stimuli.
Our primary hypothesis is that smoking abstinence will result in impaired sustained
attention accompanied by decreases in blood-oxygenation-level-dependent (BOLD) fMRI signal
in regions associated with sustained attention including right fronto-parietal cortex,
thalamus and reticular activation system. Abstinence may also result in performance-related
increases in activation in brain regions associated with effortful processing including the
anterior cingulate cortex. We also hypothesize that smokers during the satiated state will
exhibit brain activity more similar to that of non-smokers.
In addition to task related brain responses, we will also measure changes in absolute
regional cerebral blood flow (rCBF) and hypothesize that abstinence will result in
significant decreases in regions associated with arousal (e.g., reticular activation
system); information processing (e.g., thalamus); and emotional regulation (e.g., anterior
cingulate cortex, prefrontal cortex).
Following an extended training period in which performance will become stable, smokers will
be tested in the 4 Tesla MRI scanner (GE LX NVi system) 24 hours after quitting smoking, and
tested satiated, while non-smokers will be tested in the scanner once under normal
conditions. This design will provide an assessment of how tobacco abstinence alters
information processing.
Included smoker participants will smoke at least 10 cigarettes per day of a brand delivering
at least 0.5 mg nicotine (by FTC method) for at least two years and have afternoon end tidal
carbon monoxide (CO) concentrations of at least 10 ppm (confirming they are inhalers).
Inclusion criteria for non-smoker participants is that they should have smoked less than 50
cigarettes in their lifetime, have not smoked or used any nicotine products during the last
6 months, and have afternoon end tidal CO of less than or equal to 5 ppm. In order to reduce
variability and ensure comparable stimulus exposure, participants will be required to be
right-handed, and have at least 20-30 corrected vision.
During a screening session, all aspects of the study will be described to subjects and
informed consent will be acquired. Breath and saliva samples will be collected in order to
verify smoking status; and paper-and-pencil measures of smoking history, nicotine
dependence, and mood will be collected. Each subject will also complete a Brain Imaging and
Analysis Center (BIAC) approved fMRI subject screening form. For females of child bearing
potential, a blood sample will be taken for pregnancy testing. For all participants, a urine
sample will be taken for illicit drug testing. Finally, each subject will be escorted to the
hospital where they will view and be placed in a mock fMRI scanner for a short time in order
to increase familiarity with study procedures. Subjects who meet all selection criteria will
be scheduled for the remainder of sessions.
Participants will learn and practice a sustained attention task. The planned sustained
attention task, called the rapid visual information processing task (RVIP) requires
participants to identify series of three odd or three even numbers among a series of numbers
presented one at a time on a computer monitor. A control task in which participants press a
button when they see a '0' will also be practiced. Total task time is 15 minutes (practice
version) and each participant will be required to complete as many as 8 practice versions or
until 50% accuracy is achieved on two consecutive attempts. Training may require 2-8 visits
but will not exceed 2 hours and 40 minutes in total duration. One practice version of the
task will be conducted in the mock fMRI scanner.
Following the training period, smoker participants will complete two fMRI scans and
non-smokers will complete one fMRI scan in which they will complete 1) undergo a five minute
resting state BOLD scan, 2) two 12.5 minute versions of the RVIP and 3) a 12.5-minute
'cue-viewing' task in which they view pictures of people smoking. For the 'satiated'
sessions, smoker participants will be instructed to smoke as usual before and after the
session. For the 'abstinent' session, smoker participants will be required to quit smoking
for 24 hours prior to the scan and 24 hours following the scan. Quitting will be verified
using CO and salivary cotinine and nicotine levels collected at the time of the scan and a
short session 24 hours after the scan. All smoker participants will be given information
about quitting smoking for 48 hours and we will answer questions about quitting smoking. The
order of the sessions—satiated first vs. abstinent first—will be randomly assigned.
One week after their second scan, participants will attend a 30-minute office visit in which
they will complete questionnaires and the RVIP task.
;
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT03931772 -
Online Automated Self-Hypnosis Program
|
N/A | |
Completed |
NCT02649556 -
A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2
|
N/A | |
Completed |
NCT03901066 -
Smoking Dependence and Periodontitis
|
||
Recruiting |
NCT05846841 -
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
|
N/A | |
Completed |
NCT03170752 -
Implementing and Testing a Cardiovascular Assessment Screening Program (CASP)
|
N/A | |
Completed |
NCT03305978 -
Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan.
|
N/A | |
Completed |
NCT00000437 -
Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)
|
Phase 4 | |
Completed |
NCT06105424 -
BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability
|
N/A | |
Active, not recruiting |
NCT02752022 -
Monitoring the Transition From Smoking to E-cigarettes
|
||
Completed |
NCT04340830 -
The Effect of Smoking on Dimensional Changes of Free Gingival Graft Around Dental Implants
|
N/A | |
Completed |
NCT02912000 -
TEACH: Technology Evaluation to Address Child Health
|
N/A | |
Completed |
NCT02901171 -
The Contribution of a Smartphone Application to Acceptance and Commitment Therapy Group Treatment for Smoking Cessation
|
N/A | |
Completed |
NCT03206619 -
A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
|
||
Completed |
NCT02949648 -
Electronic Cigarette Use and Quitting in Youth
|
N/A | |
Completed |
NCT02246114 -
Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women
|
N/A | |
Completed |
NCT02945371 -
Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life
|
N/A | |
Completed |
NCT01898507 -
Nicotine Metabolism and Low Nicotine Cigarettes
|
N/A | |
Completed |
NCT03448900 -
Intervention Study for Smoking Cessation in Spanish College Students
|
N/A | |
Completed |
NCT01954407 -
Young Adults' Responses to Anti-smoking Messages
|
N/A |